biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Denali Therapeutics vs Annexon, Inc.....!!

<< Previous

Bullboard Posts

Next >>

Post by narmacon Jan 27, 2023 10:59am

323 Views

Post# 35250120

Denali Therapeutics vs Annexon, Inc.....!!

The previous and present management teams have compared Bioasis to the above companies. DrDR bringing Annexon into the fold as a comparative company which is in a similar stage of development. Nothing has changed except shareprice.

Todays market Caps for these companies are;

Denali ------DNLI-------- $4.24 Billion USD.

Annexon -------ANNX------ $340 Million USD.

Bioasis -------BIOAF---------- $ 2.1 Million USD.

We have incredible upside when our progressive forward plan is put in place!!

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!